Postoperative Management of Thyroid Cancer

  • Beng K. YapEmail author


Differentiated thyroid carcinoma refers to both papillary and follicular thyroid carcinomas arising from thyroid follicular epithelium


Total Thyroidectomy Follicular Thyroid Carcinoma American Thyroid Association Thyroid Remnant Thyroid Hormone Withdrawal 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References and Further Reading

  1. British Thyroid Association, Royal College of Physicians London. Guidelines for the management of thyroid cancer. 2nd ed. London: British Thyroid Association and Royal College of Physicians; 2007.Google Scholar
  2. Catargi B, Borget I, Deandreis D, Zerdoud S, Bridji B, Bardet S, Rousseau A, Bastie D, Schvartz C, Vera P, Morel O, Benisvy D, Bournaud C, Bonichon F, Dejax C, Toubert ME, Benhamou E, Schlumberger M. Comparison of four strategies of radioiodine ablation in patients with thyroid cancer with low-risk of recurrence: the randomized, prospective ESTIMABL study on 753 patients. Paris: International Thyroid Congress; 2010. Abstract OC-067.Google Scholar
  3. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Pacini F, Schlumberger M, Sherman SI, Steward DL, Tuttle RM. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009;19(11):1167–214.PubMedCrossRefGoogle Scholar
  4. Kloos RT, Eng C, Evans DB, Francis GL, Gagel RF, Gharib H, Moley JF, Pacini F, Ringel MD, Schulumberger M, Wells SA. Medullary thyroid carcinoma: management guidelines of the American Thyroid Association. Thyroid. 2009;19(6):565–612.PubMedCrossRefGoogle Scholar
  5. Mallick U, Harmer C, Clarke S, Moss L, Nicol A, Clarke P, Smellie J, McCready R, Farnell K, Franklyn J, John R, Nutting C, Yap B, Lemon C, Wadlsey J, Gerrard G, Roques T, Macias E, Whitaker S, Abdul-Hamid A, Alvarez P, Kadalayil L, Hackshaw A. HiLo. Multicentre randomised phase III clinical trial of high versus low dose radioiodine, with or without recombinant human thyroid stimulating hormone (rhTSH), for remnant ablation for differentiated thyroid cancer. Paris: International Thyroid Congress; 2010. Abstract OC-068.Google Scholar
  6. Pacini F, Schlumber M, Dralle H, Elisei R, Smit JWA, Wiersinga W, European Thyroid Cancer Taskforce. European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol. 2008;154:787–803.CrossRefGoogle Scholar

Copyright information

© Springer-Verlag London 2014

Authors and Affiliations

  1. 1.Department of Clinical OncologyThe Christie NHS Foundation TrustManchester, LancashireUK

Personalised recommendations